Use and validation of epithelial recognition and fields of view algorithms on virtual slides to guide TMA construction.

While tissue microarrays (TMAs) are a form of high-throughput screening, they presently still require manual construction and interpretation. Because of predicted increasing demand for TMAs, we investigated whether their construction could be automated. We created both epithelial recognition algorithms (ERAs) and field of view (FOV) algorithms that could analyze virtual slides and select the areas of highest cancer cell density in the tissue block for coring (algorithmic TMA) and compared these to the cores manually selected (manual TMA) from the same tissue blocks. We also constructed TMAs with TMAker, a robot guided by these algorithms (robotic TMA). We compared each of these TMAs to each other. Our imaging algorithms produced a grid of hundreds of FOVs, identified cancer cells in a stroma background and calculated the epithelial percentage (cancer cell density) in each FOV. Those with the highest percentages guided core selection and TMA construction. Algorithmic TMA and robotic TMA were overall approximately 50% greater in cancer cell density compared with Manual TMA. These observations held for breast, colon, and lung cancer TMAs. Our digital image algorithms were effective in automating TMA construction.

[1]  Ash A. Alizadeh,et al.  Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. , 2002, The American journal of pathology.

[2]  Yasodha Natkunam,et al.  Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.

[3]  Anil K. Jain Fundamentals of Digital Image Processing , 2018, Control of Color Imaging Systems.

[4]  Daniel Birnbaum,et al.  Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers , 2006, Clinical Cancer Research.

[5]  Lawrence H. Staib,et al.  The image processing handbook, 2nd edition J. C. Russ , 1998, Journal of Nuclear Cardiology.

[6]  K. Pienta,et al.  Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis , 2002, The American journal of surgical pathology.

[7]  A. Mobasheri,et al.  Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery. , 2004, Histology and histopathology.

[8]  Kyle Porter,et al.  Semi‐automated imaging system to quantitate Her‐2/neu membrane receptor immunoreactivity in human breast cancer , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[10]  Kurt Zatloukal,et al.  Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner. , 2003, BioTechniques.

[11]  M. Rubin,et al.  Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. , 2001, The American journal of pathology.

[12]  O. Kallioniemi,et al.  Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer † , 2002, Genes, chromosomes & cancer.

[13]  John C. Russ,et al.  The image processing handbook (3. ed.) , 1995 .

[14]  Sanford H Barsky,et al.  Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. , 2003, Experimental and molecular pathology.

[15]  S H Barsky,et al.  Semi‐automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer , 2007, Journal of microscopy.

[16]  Sankar K. Pal,et al.  Image segmentation using fuzzy correlation , 1992, Inf. Sci..

[17]  H. Moch,et al.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.